Condition
DBS
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07369310Not ApplicableNot Yet Recruiting
Comparing Biomarker-Guided DBS Programming With Standard Clinical Monopolar Programming
NCT05103384Completed
Utilizing Neural Signatures and Virtual Reality to Advance DBS Programming
NCT04361955Not ApplicableCompletedPrimary
Modulatory Effects of Deep Brain Stimulation on Cerebral Cortical Activity
NCT01274832Unknown
Prospective Study to Compare Results of STN-DBS Between Early Treated and Late-treated PD Patient
Showing all 4 trials